Clinical Trial

Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome

Name: Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome — clinical trial record (NCT06198842)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The aim of the current study is to evaluate the safety and efficacy of low dose treosulfan based conditioning regimen in HSCT with post-transplant cyclophosphamide in Nijmegen breakage syndrome

Trial Details

NCT Number	NCT06198842
Lead Sponsor	Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Conditions	Nijmegen Breakage Syndrome
Enrollment	10 participants
Start Date	2023-11-22
Primary Completion	2027-01-31 (estimated)
Study Completion	2029-01-31 (estimated)
Updated on ClinicalTrials.gov	2024-01-10